MARKET

OGEN

OGEN

Oragenics
AMEX

Real-time Quotes | Nasdaq Last Sale

0.3398
+0.0197
+6.15%
Opening 15:26 05/27 EDT
OPEN
0.3249
PREV CLOSE
0.3201
HIGH
0.3451
LOW
0.3201
VOLUME
549.07K
TURNOVER
116.23K
52 WEEK HIGH
1.150
52 WEEK LOW
0.2184
MARKET CAP
39.55M
P/E (TTM)
-2.3896
1D
5D
1M
3M
1Y
5Y
Oragenics Chair Sends Letter To Shareholders
Oragenics, Inc. (NYSE:OGEN) (“Oragenics” or the “Company”) today issued the following letter to shareholders from its Executive Chairman, Frederick W. Telling, Ph.D.: To My Fellow
Benzinga · 05/17 11:39
Oragenics Issues Letter to Shareholders
TAMPA, Fla., May 17, 2022--Oragenics Issues Letter to Shareholders
Business Wire · 05/17 11:30
Here's why meme stocks are hinting at another flashy rally for `junk stocks`
We've seen this movie before only to watch dip-buyers get fleeced — but money managers are now warming to the idea of a material bounce in stocks.
Yahoo Finance · 05/13 20:17
Oragenics's Earnings: A Preview
Oragenics (AMEX:OGEN) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Oragenics will report an earnings per share (EPS) of $-0.02.
Benzinga · 04/26 20:04
Oragenics to Participate at the World Vaccine Congress Washington 2022
TAMPA, Fla., April 18, 2022--Oragenics to Participate at the World Vaccine Congress Washington 2022
Business Wire · 04/18 11:30
Executives Buy Around $5.5M Of 3 Penny Stocks
US crude oil futures traded higher on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in ...
Benzinga · 04/04 16:54
4 Penny Stocks Insiders Are Buying
US crude oil futures traded sharply lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ...
Benzinga · 03/31 10:16
Oragenics drops after flagging audit concerns
Development stage biotech, Oragenics (OGEN -10.5%) has recorded the biggest intraday loss in a year on Friday after the company said that its financial statements contained an unqualified audit opinion
Seekingalpha · 03/25 18:14
More
No Data
Learn about the latest financial forecast of OGEN. Analyze the recent business situations of Oragenics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average OGEN stock price target is 2.250 with a high estimate of 2.250 and a low estimate of 2.250.
High2.250
Average2.250
Low2.250
Current 0.3301
EPS
Actual
Estimate
-0.04-0.03-0.02-0.01
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 18
Institutional Holdings: 6.33M
% Owned: 5.43%
Shares Outstanding: 116.39M
TypeInstitutionsShares
Increased
4
857.31K
New
5
128.78K
Decreased
2
2.71M
Sold Out
2
2.98M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+3.72%
Pharmaceuticals & Medical Research
+1.28%
Key Executives
Chairman/Executive Director
Frederick Telling
Chief Executive Officer/Chief Financial Officer/Treasurer/Secretary
Michael Sullivan
Independent Director
Alan Dunton
Independent Director
Robert Koski
Independent Director
Kimberly Murphy
Independent Director
Charles Pope
No Data
No Data
About OGEN
Oragenics, Inc. is a developing-stage company. The Company is focused on developing infectious diseases including coronaviruses and multidrug-resistant organisms. The Company’s pre-clinical product candidates includes OG716 and Terra CoV-2. It, through its subsidiary, is engaged in the research and development of Terra CoV-2 vaccine product candidate. It is also engaged in the development of its lead lantibiotic candidate, OG716, to treat Clostridium difficile.

Webull offers kinds of Oragenics Inc stock information, including AMEX:OGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OGEN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OGEN stock methods without spending real money on the virtual paper trading platform.